Meghmani Organics Q4 FY26 Earnings Call Transcript Released
Meghmani Organics Limited released its Q4 FY26 earnings call transcript. Standalone FY26 revenue grew 4% to ₹2,091 crore, with EBITDA up 27% to ₹228.7 crore. Consolidated revenue rose 5% to ₹2,174 crore, and EBITDA increased 24% to ₹176 crore. The company established a Brazil subsidiary and received approval for nano fertilizers. TiO2 plant operations are temporarily suspended.
The announcement provides detailed financial results for Q4 FY26 and the full year, along with strategic updates like the Brazil subsidiary and nano fertilizer approvals. However, the temporary suspension of the TiO2 plant and ongoing macroeconomic challenges temper the immediate impact.
The announcement is a transcript of an earnings call. While it provides financial results and strategic updates, the overall sentiment is neutral as it details both positive developments like subsidiary establishment and financial growth, alongside challenges such as the TiO2 plant suspension and macroeconomic headwinds.
Meghmani Organics Limited (MOL) has released the transcript of its Earnings Conference Call held on May 16, 2026, to discuss the financial results for the fourth quarter and full year of FY26. The call featured insights from Chairman and Managing Director Mr. Ankit Patel, CFO Mr. G.S. Chahal, and Investor Relations Mr. Nishant Vyas, with moderation by Ms. Rashmi Gohil from Arihant Capital Markets Limited.
During the call, Mr. Ankit Patel highlighted key corporate developments, including the establishment of a wholly-owned subsidiary in Brazil to strengthen access to the agrochemical market, and an upgrade to an EcoVadis Silver Medal for sustainability. The company also signed an agreement to procure 3.3 MW of wind and solar hybrid power, aiming to increase renewable energy consumption to over 50%.
Regarding financial performance, on a standalone basis for FY26, revenue stood at ₹2,091 crores, a 4% year-on-year increase, with EBITDA growing by 27% to ₹228.7 crores. The Crop Protection segment contributed 78% to the revenue, while the Pigments segment accounted for 22%. The Crop Protection segment reported revenue of ₹1,631 crores and EBITDA of ₹244 crores with a 15% EBITDA margin. The Pigments segment reported revenue of ₹461 crores and EBITDA of ₹15 crores with a 3.3% EBITDA margin.
On a consolidated basis for FY26, revenue was ₹2,174 crores, up 5% year-on-year, and EBITDA was ₹176 crores, up 24% year-on-year, with an EBITDA margin of 8.1%. Total debt on a standalone basis was ₹528 crores, and on a consolidated basis was ₹722 crores.
The company temporarily suspended operations at its Titanium Dioxide (TiO2) plant due to commercial unviability caused by elevated raw material costs and weaker price realization. The management is awaiting an announcement from DGTR regarding anti-dumping duties for TiO2, expected within one to two months. The company also received approval for manufacturing nano fertilizer products like Nano DAP, Nano NPK, and Nano Zinc, with commercial production expected to commence during the Kharif season.
A scheme of amalgamation for wholly-owned subsidiaries Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited with Meghmani Organics Limited was filed, aiming for operational and financial synergies. The company expects better revenue and profitability in FY27 and plans to provide a reasonably good dividend to investors, subject to board approval.
What to do with a filing like this
Meghmani Organics Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Meghmani Organics Limited. Read the original for the full detail.